文献速递造血干细胞移植与细胞治疗淋巴瘤白血病

移植物中调节性T细胞含量增高与造血干细胞移植结局改善相关:一项系统综述

Increased regulatory T cell graft content is associated with improved outcome in haematopoietic stem cell transplantation: a systematic review.
PubMed 文献 · Br J Haematol · 2017-01-17

本系统综述纳入14项报告血液系统恶性肿瘤患者造血干细胞移植移植物中调节性T细胞(Treg)组成的研究,其中8项按Treg绝对剂量或与CD3+、CD4+细胞比值对患者分层。荟萃分析显示,移植物中高Treg水平与总生存改善、非复发死亡显著降低及急性移植物抗宿主病风险降低相关。

要点

  • 移植物高Treg水平与总生存改善相关(HR 0.42,95%CI 0.23-0.74,P=0.003,2项研究)
  • 移植物高Treg水平与非复发死亡显著降低相关(HR 0.30,95%CI 0.14-0.64,P=0.002,2项研究)
  • 移植物高Treg水平与急性GVHD风险降低相关(RR 0.59,95%CI 0.40-0.89,P=0.01,6项研究)

核心结论

  • 移植物中Treg组成对异基因HSCT的成功有强大影响,这些发现的一致性强烈提示这一点。
  • 主要挑战是将这些发现转化为更好地选择移植物和未来供者,以实质性改善异基因HSCT的结局和实践。

研究设计与样本

  • 系统综述,纳入14项报告血液系统恶性肿瘤患者HSCT移植物Treg组成的研究,其中8项按Treg绝对剂量或与CD3+、CD4+细胞比值对患者分层。

主要发现

  • 移植物中高Treg水平与总生存改善相关(HR 0.42,95%CI 0.23-0.74,P=0.003,2项研究)。
  • 移植物中高Treg水平与非复发死亡显著降低相关(HR 0.30,95%CI 0.14-0.64,P=0.002,2项研究)。
  • 移植物中高Treg水平与急性GVHD风险降低相关(RR 0.59,95%CI 0.40-0.89,P=0.01,6项研究)。

关键数值与推荐

  • 全文未汇总统一的Treg阈值或分层标准,8项研究分别以Treg绝对剂量或与CD3+、CD4+细胞的比值进行分层。

临床怎么用

  • 作者认为主要挑战是将这些发现转化为更好地选择移植物和未来供者,以实质性改善异基因HSCT的结局和实践。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Allogeneic haematopoietic stem cell transplant (HSCT) recipients are at increased risk of morbidity and mortality, often due to the development of acute or chronic graft-versus-host disease (GVHD). Low numbers or proportions of regulatory T cells (Tregs) have been reported in patients who develop GVHD. We undertook a systematic review of studies that reported the Treg composition of HSCT grafts in patients with haematological malignancies. Fourteen eligible studies were identified, eight of which stratified patients by Tregs (absolute dose or ratio to CD3+ or CD4+ cells). Meta-analyses showed that high levels of Tregs in the grafts were associated with improved overall survival [hazard ratio (HR) 0·42, 95% confidence interval (CI) 0·23-0·74, P = 0·003, 2 studies], with a significant reduction in non-relapse mortality (HR 0·30, 95% CI 0·14-0·64, P = 0·002, 2 studies) and a reduced risk of acute GVHD (relative risk (RR) 0·59, 95% CI 0·40-0·89, P = 0·01, 6 studies). The consistency of these findings strongly suggests that the Treg composition of HSCT grafts has a powerful effect on the success of allogeneic HSCT. The major challenge is to translate these findings into better selection of allografts and future donors to provide a substantial improvement in allogeneic HSCT outcomes and practice.

来源:Br J Haematol,查看原文。版权归原作者所有。

引用

  1. Fisher SA, Lamikanra A, Dorée C, et al. Increased regulatory T cell graft content is associated with improved outcome in haematopoietic stem cell transplantation: a systematic review. Br J Haematol. 2017. PMID: 28094847. doi:10.1111/bjh.14433

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。